Journal of Commercial Biotechnology announces publication of July issue

WASHINGTON - June 30, 2013 - PRLog -- The Journal of Commercial Biotechnology, in print since 1994, is the definitive international quarterly publication for bioscience business professionals. The Journal is designed specifically for those professionals who need to enhance their knowledge of biotechnology business strategy and management, improve and advance their product development or want to keep up-to-date with current issues and industry trends.

Complete details and the latest issue are available at http://CommercialBiotechnology.com .

Journal of Commercial Biotechnology Vol 19, Issue 3 (2013)

Patenting human genes and mutations: A personal perspective
- Ananda Mohan Chakrabarty

The polyvalent scientist: the added value of management training
- Maria Theodosiou, Arsia Amir-Aslani

A Role for Virtual Biotechnology Companies in Drug Discovery and Development?
- Dianne Nicol, Johnathon Liddicoat, Christine Critchley

The role of specialization in mutual fund investment strategies: An exploratory study of the life sciences industry.
- Osne Frans Kirzner, Lorraine Marie Uhlaner

Culture and the Principles of Biomedical Ethics
- Kola Abimbola

The relevance and importance of business development and licensing in the biopharmaceutical industry.
- Roger Davies

Patent Licensing Considerations for Biologics under the BPCIA
- Sheila Swaroop, Carol Pitzel Cruz

Evergreening patents: The Indian Supreme Court rejects patenting of incremental improvements
- Joanna Brougher

The life sciences industry and the changing IP landscape
- Gareth Williams

EU Legal & Regulatory Update
- Ewan Grist

Book Review: The crowdfunding revolution: How to raise venture capital using social media
- Steven S. Ma